The authors demonstrated that, with EGFR-targeting and macropinocytosis-intensifying bifunctional attributes, Fv-LDP-D3 has shown the remarkable potential of tumor imaging and prominent tumor inhibition in AsPC-1 (human pancreatic cancer cells with a homozygous KRASG12D mutation)-derived xenografts. Here, EGFR is linked to neoplasm.